CTRI/2023/03/050531Not yet recruitingPhase 2
Evaluation of anti-Cataract activity of NIF herbal medication [Eye drop] in Senile Immature Cataract condition.
ational Innovation Foundation0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 2
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •The inclusion criteria is to have patients with age Group 60 years and above either gender diagnosed with Senile immature Cataract
Exclusion Criteria
- •The exclusion criteria for the research program viz., Cataracts other than senile immature cataract; History of any Systemic diseases; If HbA1C more than 6.5; Patients having Glaucoma; Corneal ulcer, Dacryocystitis or any type of Ocular surface or retinal pathology will be excluded, Sluggish Pupillary reaction; Hypersensitivity to the test drug and Patient(s) not willing to give consent.
Investigators
Similar Trials
Recruiting
Phase 2
Study on Herbal extracts in learning and cognitive changesCTRI/2022/09/045651MVR Ayurveda Medical college
Not yet recruiting
Phase 3
The effect of klatin capsule on type 2 diabetesType 2 diabetes mellitus.Type 2 diabetes mellitus without complicationsE11.9IRCT20210724051965N1Mazandaran University of Medical Sciences66
Not yet recruiting
Phase 2
Study to evaluate the efficacy of herbal neutraceuticals in immunity and gut healthCTRI/2023/02/049916MVR Ayurveda medical college and hospital
Recruiting
Phase 2
oscatem and COVID-19COVID-19 disease.COVID-19U07.1IRCT20180103038199N11Mashhad University of Medical Sciences70
Recruiting
Phase 2
clinical study on herbal neutraceuticals in mood changesCTRI/2023/02/049699MVR Ayurveda medical college and hospital